Table 1.
Characteristics of contraceptive users and claims by year
| Patient and plan characteristics | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|
| Patient characteristics* | ||||
| Mean age in years (SD) | 30.2 (7.5) | 29.6 (7.4) | 29.2 (7.4) | 28.9 (7.5) |
| Age groups, N (%) | ||||
| 18–25 years | 491,114 (33.7) | 715,583 (37.3) | 794,570 (39.5) | 681,603 (41.5) |
| 26–35 years | 572,156 (39.3) | 743,736 (38.7) | 763,625 (38.0) | 595,321 (36.3) |
| 36–45 years | 393,201 (27.0) | 460,505 (24.0) | 453,369 (22.5) | 364,718 (22.2) |
| Region, N (%) | ||||
| Northeast | 221,605 (15.2) | 332,637 (17.3) | 369,269 (18.4) | 306,070 (18.6) |
| Midwest | 382,639 (26.3) | 470,737 (24.5) | 491,813 (24.5) | 369,927 (22.5) |
| South | 575,189 (39.5) | 732,673 (38.2) | 734,789 (36.5) | 570,918 (34.8) |
| West | 272,358 (18.7) | 335,105 (25.2) | 374,894 (28.2) | 346,734 (21.1) |
| Unknown | 4,680 (0.32) | 48,672 (2.5) | 40,799 (2.0) | 47,993 (2.9) |
| Relationship of patient to employer, N (%) | ||||
| Employee | 732,242 (50.3) | 938,418 (48.9) | 954,256 (47.4) | 749,069 (45.6) |
| Spouse | 296,186 (20.3) | 367,770 (19.2) | 380,568 (18.9) | 302,987 (18.5) |
| Dependent | 428,043 (29.4) | 613,636 (32.0) | 676,740 (29.3) | 589,586 (35.9) |
| Health plan types, N (%) | ||||
| Comprehensive | 14,803 (1.0) | 15,414 (0.8) | 16,885 (0.8) | 16,299 (1.0) |
| Exclusive provider organization and health maintenance organization | 282,841 (19.4) | 334,459 (17.4) | 291,567 (14.5) | 267,670 (16.3) |
| Point-of-service | 113,557 (7.8) | 144,256 (7.5) | 142,920 (7.1) | 134,357 (8.2) |
| Preferred-provider organization | 905,479 (62.2) | 1,168,956 (60.9) | 1,266,136 (62.9) | 972,178 (59.2) |
| Consumer-driven and high-deductible health plans | 107,110 (7.4) | 147,800 (7.7) | 170,680 (8.5) | 227,626 (13.9) |
| Missing | 32,681 (2.2) | 108,939 (5.7) | 123,376 (6.1) | 23,512 (1.4) |
| Contraceptive types per claim, N (%)** | ||||
| Branded Oral | 2,136,905 (24.8) | 2,401,637 (21.8) | 2,281,642 (19.9) | 1,640,624 (17.3) |
| Generic Oral | 5,650,271 (65.6) | 7,596,218 (68.8) | 8,088,701 (70.6) | 6,923,986 (73.0) |
| Injection | 76,693 (0.9) | 107,583 (1.0) | 117,291 (1.0) | 117,281 (1.2) |
| Patch | 113,094 (1.3) | 121,819 (1.1) | 107,759 (0.9) | 89,614 (0.9) |
| Ring | 546,419 (6.4) | 684,323 (6.2) | 693,499 (6.1) | 561,134 (5.9) |
| IUD | 78,406 (0.9) | 117,614 (1.1) | 142,717 (1.3) | 136,333 (1.4) |
| Implant | 7,414 (0.1) | 13,548 (0.1) | 18,494 (0.2) | 22,260 (0.2) |
| Rates of $0 cost-sharing for different contraceptive types N(%)** | ||||
| Branded Oral | 189,428 (8.9) | 165,837 (6.9) | 220,522 (9.7) | 880,385 (53.7) |
| Generic Oral | 523,590 (9.3) | 587,305 (7.7) | 1,004,033 (12.4) | 5,562,270 (80.3) |
| Injection | 7,390 (9.6) | 8,839 (8.2) | 13,940 (11.9) | 88,215 (75.2) |
| Patch | 9,763 (8.6) | 8,250 (6.8) | 11,790 (10.9) | 58,926 (65.8) |
| Ring | 47,498 (8.7) | 49,655 (7.3) | 78,826 (11.4) | 369,619 (65.9) |
| IUD | 28,724 (36.6) | 44,002 (37.4) | 57,406 (40.2) | 119,423 (87.6) |
| Implant | 2,308 (9.3) | 4,263 (31.1) | 6,283 (34.0) | 17,914 (80.5) |
*
Distribution of patient and contraceptive characteristics at the time of the first contraceptive claim per year for each patient. A patient’s characteristics could be represented in multiple years if she had claims in multiple years.
**
Among all contraceptive claims